Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Bladder Dysfunction Reports
Published in: Current Bladder Dysfunction Reports 3/2022

Open Access 23-06-2022 | Chlamydia Trachomatis | Inflammatory/Infectious Bladder Disorders (M. Sherif Mourad, Section Editor)

Updates on Sexually Transmitted Urethro-cystitis

Authors: Mostafa M. Mostafa, Ayman Mahdy, Gamal Ghoniem

Published in: Current Bladder Dysfunction Reports | Issue 3/2022

Login to get access

Abstract

Purpose of Review

We performed recent literature review with the aim to address the updates in diagnosis and management of sexually transmitted urethro-cystitis.

Recent Findings

There are multiple, recently published studies that collectively lead to an organized stepwise plan for diagnosis and management of sexually transmitted urethro-cystitis.

Summary

Sexually transmitted urethro-cystitis is a common health condition that can be managed efficiently if the appropriate steps are taken in diagnosis and management.
Literature
1.
Bartoletti R, Wagenlehner FME, Bjerklund Johansen TE, Koves B, Cai T, Tandogdu Z, et al. Management of urethritis: is it still the time for empirical antibiotic treatments? Eur Urol Focus. 2019;5(1):29–35.PubMedCrossRef
2.
Workowski KA, Bolan GA. Centers for Disease C, Prevention Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1–137.PubMed
3.
Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97(8):548–62.PubMedPubMedCentralCrossRef
4.
5.
Wangu Z, Burstein GR. Adolescent sexuality: updates to the sexually transmitted infection guidelines. Pediatr Clin North Am. 2017;64(2):389–411.PubMedCrossRef
6.
Gilbert LK, Levandowski BA, Roberts CM. Characteristics associated with genital herpes testing among young adults: assessing factors from two national data sets. J Am Coll Health. 2010;59(3):143–50.PubMedCrossRef
7.
Wu LT, Ringwalt CL, Patkar AA, Hubbard RL, Blazer DG. Association of MDMA/ecstasy and other substance use with self-reported sexually transmitted diseases among college-aged adults: a national study. Public Health. 2009;123(8):557–64.PubMedCrossRef
8.
Vivancos R, Abubakar I, Hunter PR. Foreign travel, casual sex, and sexually transmitted infections: systematic review and meta-analysis. Int J Infect Dis. 2010;14(10):e842–51.PubMedCrossRef
9.
Mayor MT, Roett MA, Uduhiri KA. Diagnosis and management of gonococcal infections. Am Fam Physician. 2012;86(10):931–8.PubMed
10.
Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet. 1998;351(Suppl 3):5–7.PubMedCrossRef
11.
Soda M, Ito S, Matsumaru N, Nakamura S, Nagase I, Takahashi H, et al. Evaluation of the microbiological efficacy of a single 2-gram dose of extended-release azithromycin by population pharmacokinetics and simulation in Japanese patients with gonococcal urethritis. Antimicrob Agents Chemother. 2017;62(1):e01409-17. https://​doi.​org/​10.​1128/​AAC.​01409-17.
12.
Yasuda M, Ito S, Hatazaki K, Deguchi T. Remarkable increase of Neisseria gonorrhoeae with decreased susceptibility of azithromycin and increase in the failure of azithromycin therapy in male gonococcal urethritis in Sendai in 2015. J Infect Chemother. 2016;22(12):841–3.PubMedCrossRef
13.
Yates AB. Management of patients with a history of allergy to beta-lactam antibiotics. Am J Med. 2008;121(7):572–6.PubMedCrossRef
14.
Moran JS, Levine WC. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis. 1995;20(Suppl 1):S47-65.PubMedCrossRef
15.
Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis. 2007;44(Suppl 3):S84-101.PubMedCrossRef
16.
17.
Peterman TA, Tian LH, Metcalf CA, Satterwhite CL, Malotte CK, DeAugustine N, et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med. 2006;145(8):564–72.PubMedCrossRef
18.
Turner AN, Feldblum PJ, Hoke TH. Baseline infection with a sexually transmitted disease is highly predictive of reinfection during follow-up in Malagasy sex workers. Sex Transm Dis. 2010;37(9):559–62.PubMedCrossRef
19.
Gaydos C, Maldeis NE, Hardick A, Hardick J, Quinn TC. Mycoplasma genitalium compared to chlamydia, gonorrhoea and trichomonas as an aetiological agent of urethritis in men attending STD clinics. Sex Transm Infect. 2009;85(6):438–40.PubMedCrossRef
20.
Falk L, Fredlund H, Jensen JS. Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis. Sex Transm Infect. 2004;80(4):289–93.PubMedPubMedCentralCrossRef
21.
Leung A, Eastick K, Haddon LE, Horn CK, Ahuja D, Horner PJ. Mycoplasma genitalium is associated with symptomatic urethritis. Int J STD AIDS. 2006;17(5):285–8.PubMedCrossRef
22.
Moi H, Reinton N, Moghaddam A. Mycoplasma genitalium is associated with symptomatic and asymptomatic non-gonococcal urethritis in men. Sex Transm Infect. 2009;85(1):15–8.PubMedCrossRef
23.
Sena AC, Lensing S, Rompalo A, Taylor SN, Martin DH, Lopez LM, et al. Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis. 2012;206(3):357–65.PubMedPubMedCentralCrossRef
24.
Rane VS, Fairley CK, Weerakoon A, Read TH, Fehler G, Chen MY, et al. Characteristics of acute nongonococcal urethritis in men differ by sexual preference. J Clin Microbiol. 2014;52(8):2971–6.PubMedPubMedCentralCrossRef
25.
Wetmore CM, Manhart LE, Lowens MS, Golden MR, Whittington WL, Xet-Mull AM, et al. Demographic, behavioral, and clinical characteristics of men with nongonococcal urethritis differ by etiology: a case-comparison study. Sex Transm Dis. 2011;38(3):180–6.PubMedPubMedCentralCrossRef
26.
27.
Joyner JL, Douglas JM Jr, Ragsdale S, Foster M, Judson FN. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex Transm Dis. 2000;27(4):236–40.PubMedCrossRef
28.
Anderson BL, Firnhaber C, Liu T, Swarts A, Siminya M, Ingersoll J, et al. Effect of trichomoniasis therapy on genital HIV viral burden among African women. Sex Transm Dis. 2012;39(8):638–42.PubMedPubMedCentralCrossRef
29.
Klinger EV, Kapiga SH, Sam NE, Aboud S, Chen CY, Ballard RC, et al. A Community-based study of risk factors for Trichomonas vaginalis infection among women and their male partners in Moshi urban district, northern Tanzania. Sex Transm Dis. 2006;33(12):712–8.PubMedCrossRef
30.
McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis. 2007;195(5):698–702.PubMedCrossRef
31.
Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009;36(1):11–6.PubMedPubMedCentralCrossRef
32.
Povlsen K, Bjornelius E, Lidbrink P, Lind I. Relationship of Ureaplasma urealyticum biovar 2 to nongonococcal urethritis. Eur J Clin Microbiol Infect Dis. 2002;21(2):97–101.PubMedCrossRef
33.
Horner P, Thomas B, Gilroy CB, Egger M, Taylor-Robinson D. Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritis. Clin Infect Dis. 2001;32(7):995–1003.PubMedCrossRef
34.
Wetmore CM, Manhart LE, Lowens MS, Golden MR, Jensen NL, Astete SG, et al. Ureaplasma urealyticum is associated with nongonococcal urethritis among men with fewer lifetime sexual partners: a case-control study. J Infect Dis. 2011;204(8):1274–82.PubMedPubMedCentralCrossRef
35.
Couldwell DL, Gidding HF, Freedman EV, McKechnie ML, Biggs K, Sintchenko V, et al. Ureaplasma urealyticum is significantly associated with non-gonococcal urethritis in heterosexual Sydney men. Int J STD AIDS. 2010;21(5):337–41.PubMedCrossRef
36.
Khosropour CM, Manhart LE, Gillespie CW, Lowens MS, Golden MR, Jensen NL, et al. Efficacy of standard therapies against Ureaplasma species and persistence among men with non-gonococcal urethritis enrolled in a randomised controlled trial. Sex Transm Infect. 2015;91(5):308–13.PubMedCrossRef
37.
Tabrizi SN, Ling AE, Bradshaw CS, Fairley CK, Garland SM. Human adenoviruses types associated with non-gonococcal urethritis. Sex Health. 2007;4(1):41–4.PubMedCrossRef
38.
Tonsberg E, Hartgill U. The urethral smear as a tool in diagnosing adenovirus-induced urethritis. Int J STD AIDS. 2014;25(14):1047–9.PubMedCrossRef
39.
Bradshaw CS, Tabrizi SN, Read TR, Garland SM, Hopkins CA, Moss LM, et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis. 2006;193(3):336–45.PubMedCrossRef
40.
Aral SO, Patel DA, Holmes KK, Foxman B. Temporal trends in sexual behaviors and sexually transmitted disease history among 18- to 39-year-old Seattle, Washington, residents: results of random digit-dial surveys. Sex Transm Dis. 2005;32(11):710–7.PubMedCrossRef
41.
Mosher WD, Chandra A, Jones J. Sexual behavior and selected health measures: men and women 15–44 years of age, United States, 2002. Adv Data. 2005;362:1–55.
42.
43.
Berntsson M, Lowhagen GB, Bergstrom T, Dubicanac L, Welinder-Olsson C, Alvengren G, et al. Viral and bacterial aetiologies of male urethritis: findings of a high prevalence of Epstein-Barr virus. Int J STD AIDS. 2010;21(3):191–4.PubMedCrossRef
44.
Manhart LE, Khosropour CM, Liu C, Gillespie CW, Depner K, Fiedler T, et al. Bacterial vaginosis-associated bacteria in men: association of Leptotrichia/Sneathia spp. with nongonococcal urethritis. Sex Transm Dis. 2013;40(12):944–9.PubMedPubMedCentralCrossRef
45.
Horner P. The etiology of acute nongonococcal urethritis–the enigma of idiopathic urethritis? Sex Transm Dis. 2011;38(3):187–9.PubMedCrossRef
46.
Mandar R. Microbiota of male genital tract: impact on the health of man and his partner. Pharmacol Res. 2013;69(1):32–41.PubMedCrossRef
47.
48.
Ozgul A, Dede I, Taskaynatan MA, Aydogan H, Kalyon TA. Clinical presentations of chlamydial and non-chlamydial reactive arthritis. Rheumatol Int. 2006;26(10):879–85.PubMedCrossRef
49.
Geisler WM, Yu S, Hook EW 3rd. Chlamydial and gonococcal infection in men without polymorphonuclear leukocytes on gram stain: implications for diagnostic approach and management. Sex Transm Dis. 2005;32(10):630–4.PubMedCrossRef
50.
Fall B, Sow Y, Mansouri I, Sarr A, Thiam A, Diao B, et al. Etiology and current clinical characteristics of male urethral stricture disease: experience from a public teaching hospital in Senegal. Int Urol Nephrol. 2011;43(4):969–74.PubMedCrossRef
51.
Swartz SL, Kraus SJ, Herrmann KL, Stargel MD, Brown WJ, Allen SD. Diagnosis and etiology of nongonococcal urethritis. J Infect Dis. 1978;138(4):445–54.PubMedCrossRef
52.
Orellana MA, Gomez-Lus ML, Lora D. Sensitivity of Gram stain in the diagnosis of urethritis in men. Sex Transm Infect. 2012;88(4):284–7.PubMedCrossRef
53.
Rietmeijer CA, Mettenbrink CJ. Recalibrating the Gram stain diagnosis of male urethritis in the era of nucleic acid amplification testing. Sex Transm Dis. 2012;39(1):18–20.PubMedCrossRef
54.
Sarier M, Sepin N, Duman I, Demir M, Hizel A, Goktas S, et al. Microscopy of Gram-stained urethral smear in the diagnosis of urethritis: which threshold value should be selected? Andrologia. 2018;50(10): e13143.PubMedCrossRef
55.
Sarier M, Kukul E. Classification of non-gonococcal urethritis: a review. Int Urol Nephrol. 2019;51(6):901–7.PubMedCrossRef
56.
Sonnenberg P, Clifton S, Beddows S, Field N, Soldan K, Tanton C, et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet. 2013;382(9907):1795–806.PubMedPubMedCentralCrossRef
57.
Horner PJ, Blee K, Falk L, van der Meijden W, Moi H. 2016 European guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016;27(11):928–37.PubMedCrossRef
58.
Taylor SN, DiCarlo RP, Martin DH. Comparison of methylene blue/gentian violet stain to Gram’s stain for the rapid diagnosis of gonococcal urethritis in men. Sex Transm Dis. 2011;38(11):995–6.PubMedCrossRef
59.
Moi H, Haugstvedt A, Jensen JS. Spontaneous regression of untreatable Mycoplasma genitalium urethritis. Acta Derm Venereol. 2015;95(6):732–3.PubMedCrossRef
60.
McGowin CL, Rohde RE, Redwine G. Epidemiological and clinical rationale for screening and diagnosis of Mycoplasma genitalium infections. Clin Lab Sci. 2014;27(1):47–52.PubMedCrossRef
61.
62.
63.
Manhart LE, Gillespie CW, Lowens MS, Khosropour CM, Colombara DV, Golden MR, et al. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis. 2013;56(7):934–42.PubMedCrossRef
64.
Schwebke JR, Rompalo A, Taylor S, Sena AC, Martin DH, Lopez LM, et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens–a randomized clinical trial. Clin Infect Dis. 2011;52(2):163–70.PubMedPubMedCentralCrossRef
65.
Sena AC, Bachmann LH, Hobbs MM. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations. Expert Rev Anti Infect Ther. 2014;12(6):673–85.PubMedCrossRef
66.
Nanda N, Michel RG, Kurdgelashvili G, Wendel KA. Trichomoniasis and its treatment. Expert Rev Anti Infect Ther. 2006;4(1):125–35.PubMedCrossRef
67.
Kojima M, Masuda K, Yada Y, Hayase Y, Muratani T, Matsumoto T. Single-dose treatment of male patients with gonococcal urethritis using 2g spectinomycin: microbiological and clinical evaluations. Int J Antimicrob Agents. 2008;32(1):50–4.PubMedCrossRef
68.
Bonar EE, Walton MA, Caldwell MT, Whiteside LK, Barry KL, Cunningham RM. Sexually transmitted infection history among adolescents presenting to the emergency department. J Emerg Med. 2015;49(5):613–22.PubMedPubMedCentralCrossRef
69.
Newbern EC, Anschuetz GL, Eberhart MG, Salmon ME, Brady KA, De Los RA, et al. Adolescent sexually transmitted infections and risk for subsequent HIV. Am J Public Health. 2013;103(10):1874–81.PubMedPubMedCentralCrossRef
70.
Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187.PubMedPubMedCentralCrossRef
71.
Tjagur S, Mandar R, Punab M. Profile of sexually transmitted infections causing urethritis and a related inflammatory reaction in urine among heterosexual males: a flow-cytometry study. PLoS ONE. 2020;15(12): e0242227.PubMedPubMedCentralCrossRef
Metadata
Title
Updates on Sexually Transmitted Urethro-cystitis
Authors
Mostafa M. Mostafa
Ayman Mahdy
Gamal Ghoniem
Publication date
23-06-2022

Other articles of this Issue 3/2022

Current Bladder Dysfunction Reports 3/2022 Go to the issue

Voiding Dysfunction Evaluation (B Brucker and B Peyronnet, Section Editors)

Defining Bladder Outlet Obstruction in Women

Patient Engagement, Education, and Literacy for Pelvic Floor Disorders (J Anger, Section Editor)

Women’s Knowledge of Bladder Health: What We Have Learned in the Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium

Neurogenic Bladder (C Powell, Section Editor)

Recently Described Innovative Reconstruction in Neurogenic Bladder: a Review

Neurogenic Bladder (C Powell, Section Editor)

Sphincteric Injection of Botulinum Toxin for Urinary Retention due to Neurogenic Bladder

Neurogenic Bladder (C Powell, Section Editor)

Bladder Dysfunction After Ureteral Reimplantation